High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53

Tumor Biology

Volumn 19, Issue 3, 1998, Pages 176-185

  Soini, Ylermi ^a   Raunio, Hannu ^a   Pääkkö, Paavo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apoptosis; bax; bcl 2; Lymphoma; mcl 1; p53

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER GRADING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031917220     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030005     Document Type: Article

References (34)

1. Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 1994;18:51-55.
2. Kerr JFR, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013-2026.
3. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
4. White E: Life, death, and the pursuit of apoptosis. A review. Genes Dev 1996;19:1-15.
5. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 1996; 88:386-401.
6. Eerola A-K, Törmänen U, Rainio P, Vähäkangas K, Soini Y, Pääkkö P: Apoptosis in operated small cell lung carcinoma is inversely related to tumor necrosis and p53 immunoreactivity. J Pathol 1997;181:172-177.
7. Soini Y, Pääkkö P: Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Hum Pathol 1996;27:1221-1226.
8. Soini Y, Virkajärvi N, Lehto V-P, Pääkkö P: Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 1996;73: 1025-1030.
9. Törmänen U, Eerola A-K, Rainio P, Väkäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto V-P, Pääkkö P: Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995;55: 5595-5602.
10. Vaux DL, Cory S, Adams TM: bcl-2 promotes the survival of haematopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
11. Reynolds JE, Yang T, Qian LP, Jenkinson JD, Zhou P, Eastman A, Crain RW: McI-1, a member of the bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res 1994;54:6348-6352.
12. Oltvai ZN, Nillman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
13. Yin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 1994;369:321-323.
14. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by inierleukin-6. Nature 1991;352:345-347.
15. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
16. Miayshita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebernmann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9: 1799-1805.
17. Cory S: Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-543.
18. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-627.
19. Robertson MJ, Manley TJ, Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J: Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma 1995;17:51-61.
20. Fraser A, Evan G: A license to kill. Cell 1996;85:781-784.
21. Krajewski S, Bodrug S, Krajewska M, Shabalk A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of mcl-1 protein in human tissue. Differential regulation of mcl-1 and bcl-2 protein production suggests a unique role for mcl-1 in control of programmed cell death. Am J Pathol 1995;146:1309-1319.
22. Pezzella F, Gatter K: What is the value of bcl-2 protein detection for histopathologists? Histopathology 1995;26:89-93.
23. Tsujimoto Y, Cossman J, Jaffe E, Groce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443.
24. Krajewski S, Krajewska M, Shabalk A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 1994;145:1323-1336.
25. Chan JKC, Banks PM, Clearly ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Stein H, Warnke RA: A proposal for classification of lymphoid neoplasma (by the International Lymphoma Study Group). Histopathology 1994;25:517-536.
26. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, Van Dierendonck JH: A new method to detect apoptosis in paraffin sections: In situ end labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
28. Soini Y, Pääkkö P, Nuorva K, Kamel D, Lane D, Vähäkangas K: Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch A 1992;421:223-228.
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage Y4. Nature 1970;227:680-685.
30. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitro-cellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
31. Soini Y, Pääkkö P, Alavaikko M, Lane D, Vähäkangas K: p53 expression in lymphatic malignancies. J Clin Pathol 1992;45:1011-1014.
32. Symmans WF, Katz RL, Ordonez NG, Dalton H, Romaguera JE, Cabanillas F: Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation. Acta Cytol 1995;39:673-682.
33. Aftabuddin M, Yamadori I, Yoshino T, Kondo E, Akagi T: Correlation between the number of apoptotic cells and expression of the apoptosis-related antigens Fas, Le(y) and bcl-2 protein in non-Hodgkin's lymphomas. Pathol Int 1995;45:422-429.
34. Leoncini L, Del Vecchio MT, Spina D, Megha T, Barbini P, Sabattini E, Pileri S, Tosi P, Kraft R, Laissue JA: Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int J Cancer 1995;61:826-831.